Skip to content
Retro Biosciences logo — We're Adding 10 Years to Healthy Human Lifespan

Retro Biosciences

We're Adding 10 Years to Healthy Human Lifespan

Founded 2020 United States Redwood City, United States 100 employees Series A Total: $1.18B Biotechnology, Pharmaceutical

General Information

Company Name Retro Biosciences
Founded Year 2020
Location United States Redwood City, United States
Employees 100
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Business Model B2B, B2B2C
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Retro Biosciences. To contact Retro Biosciences, visit retro.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Retro Biosciences compare?

A PDF of Retro Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Retro Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Retro Biosciences

Retro Biosciences, with its compelling slogan, "We're Adding 10 Years to Healthy Human Lifespan," is dedicated to pioneering therapies that combat diseases connected to the biology of aging. By emphasizing cellular reprogramming and autophagy, their mission is to rejuvenate cell and tissue functions, ultimately aiming to extend the human lifespan by a decade of health.

Headquartered in the United States, Retro Biosciences occupies a unique space at the intersection of biotechnology and longevity science, though specific founding details and industry classifications are notably absent. Information regarding its last investment or the identity of its backers remains unspecified.

This represents an opportunity for potential investors to explore uncharted avenues in the growing longevity sector. With its focus on innovative therapies, Retro Biosciences positions itself as a promising contender in the quest to revolutionize aging as we know it.

Business keywords: cellular reprogramming, autophagy, anti-aging therapies, age-related diseases, cell rejuvenation, tissue function, longevity science, healthspan extension, regenerative medicine, biological aging, therapeutic development

Services & Products

Developing therapies to reverse and prevent age-related diseases
Research on aging mechanisms
Clinical translation of anti-aging interventions

Target Customers

Healthcare providers Pharmaceutical companies Aging research institutions Individuals interested in extending healthy lifespan

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $1.00B 2
Sam Altman, Sandro Salsano
01 Jan 2026
Early VC $180.00M 1
Sam Altman
01 Apr 2022

Retro Biosciences Alternatives & Competitors

Retro Biosciences vs

Turn Bio is developing longevity solutions to combat diseases of aging by restoring youthful perform...

15 employees
Biotechnology, Pharmaceutical
Retro Biosciences vs
Samsara Therapeutics
Samsara Therapeutics United Kingdom

Treating Neurodegenerative Disease by Restoring Autophagy

Series A
12 employees
Biopharma, Biotechnology
Retro Biosciences vs
Emtora Biosciences
Emtora Biosciences United States

Commercializing eRapa™, a novel, targeted formulation of rapamycin, for the prevention of cancer pro...

Grant
2 employees
Biotechnology, Health Care

FAQ About Retro Biosciences

We're Adding 10 Years to Healthy Human Lifespan
Retro Biosciences was founded in 2020.
Retro Biosciences is headquartered in Redwood City, United States.
Retro Biosciences operates in Biotechnology and Pharmaceutical. Its work centres on cellular reprogramming, autophagy, anti-aging therapies and age-related diseases. Its customers include Healthcare providers, Pharmaceutical companies and Aging research institutions.
Retro Biosciences has a B2B and B2B2C business model. Its revenue comes from Product Sales and Licensing.
Retro Biosciences has approximately 100 employees.
Retro Biosciences has completed 2 funding rounds, raising a total of $1.18B. The latest funding stage is Series A.
Retro Biosciences offers: Developing therapies to reverse and prevent age-related diseases, Research on aging mechanisms, Clinical translation of anti-aging interventions.
Top alternatives and competitors to Retro Biosciences include Turn Biotechnologies, Samsara Therapeutics, Emtora Biosciences, ENCEFA, Satellite Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Retro Biosciences and Turn Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Retro Biosciences, https://bouncewatch.com/company/retro-biosciences, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout